Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia. Munir T, Girvan S, Cairns DA, Bloor A, et al. N Engl J Med 2025 Jun 15. doi: 10.1056/NEJMoa2504341.

Read + Share

Amedeo Smart

Independent Medical Education

Munir T, Girvan S, Cairns DA, Bloor A, et al. Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia. N Engl J Med 2025 Jun 15. doi: 10.1056/NEJMoa2504341.
PMID: 40521799